Smith J W, Fletcher W B, Wherry P J
Postgrad Med J. 1976 Jun;52(608):399-404. doi: 10.1136/pgmj.52.608.399.
Although killed influenza vaccine given by injection is protective, able to reduce sickness absence in industry and to control influenza in the armed forces, it has not so far been possible to demonstrate more than a small effect on the disease in otherwise healthy adults in industry and offices in the United Kingdom. The reasons are probably the poor rate of acceptance of vaccine, the relatively low incidence of clinical influenza in most years, and the incomplete protection given by the vaccine. Until major epidemics can be accurately forecast it is suggested that influenza vaccination may most usefully be used on a selective basis, namely for protecting those with illness predisposing to a severe effect from influenza; persons in institutions such as schools and homes for the elderly; key workers in the general population; and persons over the age of 65 years among whom considerable mortality occurs in winters when influenza is prevalent.
尽管注射用灭活流感疫苗具有保护作用,能够减少工业领域的病假天数并控制军队中的流感疫情,但迄今为止,在英国的工业和办公室环境中,对于原本健康的成年人而言,尚未能证明该疫苗对疾病有显著效果。原因可能在于疫苗的接受率较低、大多数年份临床流感的发病率相对较低以及疫苗提供的保护并不完全。在能够准确预测重大疫情之前,建议流感疫苗接种可在选择性基础上使用,即用于保护那些因疾病易受流感严重影响的人群;学校和养老院等机构中的人员;普通人群中的关键岗位工作人员;以及65岁以上人群,在流感流行的冬季,这一年龄段人群的死亡率相当高。